Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $89.34 and last traded at $88.8640, with a volume of 17165 shares trading hands. The stock had previously closed at $87.16.
Analyst Ratings Changes
Several research analysts have commented on the company. Citigroup started coverage on Henry Schein in a research note on Wednesday, April 15th. They issued a “buy” rating and a $100.00 target price for the company. Mizuho cut their price objective on shares of Henry Schein from $88.00 to $82.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. BMO Capital Markets initiated coverage on shares of Henry Schein in a report on Wednesday, July 8th. They set a “market perform” rating and a $85.00 target price on the stock. UBS Group restated a “neutral” rating and set a $85.00 price target (down from $87.00) on shares of Henry Schein in a research report on Wednesday, May 6th. Finally, BTIG Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research report on Thursday, June 11th. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $87.64.
Get Our Latest Research Report on Henry Schein
Henry Schein Price Performance
Henry Schein (NASDAQ:HSIC – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.12. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The business had revenue of $3.37 billion for the quarter, compared to the consensus estimate of $3.34 billion. During the same quarter last year, the business posted $1.15 earnings per share. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities analysts predict that Henry Schein, Inc. will post 5.32 earnings per share for the current fiscal year.
Insider Activity at Henry Schein
In other news, Director William K. Daniel acquired 10,000 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were bought at an average cost of $69.19 per share, with a total value of $691,900.00. Following the acquisition, the director owned 20,000 shares in the company, valued at approximately $1,383,800. This represents a 100.00% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.89% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the business. Assenagon Asset Management S.A. grew its stake in shares of Henry Schein by 212.8% in the fourth quarter. Assenagon Asset Management S.A. now owns 67,181 shares of the company’s stock worth $5,078,000 after purchasing an additional 45,701 shares during the last quarter. Tudor Investment Corp ET AL bought a new position in Henry Schein during the 3rd quarter valued at approximately $15,375,000. SG Americas Securities LLC lifted its holdings in Henry Schein by 171.9% in the 4th quarter. SG Americas Securities LLC now owns 820,698 shares of the company’s stock worth $62,028,000 after buying an additional 518,914 shares during the period. Heartland Advisors Inc. purchased a new stake in Henry Schein in the 4th quarter worth approximately $9,070,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of Henry Schein by 15.8% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 115,279 shares of the company’s stock worth $8,856,000 after buying an additional 15,765 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.
About Henry Schein
Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.
In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.
Read More
- Five stocks we like better than Henry Schein
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
